Literature DB >> 8195182

p21 Ras as a governor of global gene expression.

M Abdellatif1, W R MacLellan, M D Schneider.   

Abstract

The molecular mechanisms for signaling by receptor serine/threonine kinases are incompletely understood. To test the potential involvement of p21 H-Ras proteins in signal transduction for type beta transforming growth factors (TGF beta), TGF beta-responsive and constitutive reporter genes were cotransfected into cardiac myocytes and mink lung epithelial cells, with dominant inhibitory (Asn-17) or activated (Arg-12) Ras expression vectors. Asn-17 Ras inhibited both TGF beta-dependent and basal expression of inducible promoters (skeletal alpha-actin and plasminogen activator inhibitor-1), with equivalent dose-response relations. All seven reporter constructs were comparably sensitive to down-regulation by Asn-17 Ras, including those driven by nominally constitutive viral control regions or a TATA-less initiator element. All constructs were up-regulated by Arg-12 Ras more variably. Wild-type Ras had intermediate effects and could rescue a minimal thymidine kinase promoter from inhibition by dominant negative Ras. Thus, a Ras-dependent event is required for efficient expression of an unexpectedly global or inclusive set of genes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8195182

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.

Authors:  M Kretzschmar; J Doody; I Timokhina; J Massagué
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

2.  Acute targeting of general transcription factor IIB restricts cardiac hypertrophy via selective inhibition of gene transcription.

Authors:  Danish Sayed; Zhi Yang; Minzhen He; Jessica M Pfleger; Maha Abdellatif
Journal:  Circ Heart Fail       Date:  2014-11-14       Impact factor: 8.790

3.  Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation, and mitogen-activated protein kinase activity by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response.

Authors:  A Clerk; J Gillespie-Brown; S J Fuller; P H Sugden
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

4.  Gene recombination in postmitotic cells. Targeted expression of Cre recombinase provokes cardiac-restricted, site-specific rearrangement in adult ventricular muscle in vivo.

Authors:  R Agah; P A Frenkel; B A French; L H Michael; P A Overbeek; M D Schneider
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  The sodium-calcium exchanger is a mechanosensitive transporter.

Authors:  John P Reeves; Maha Abdellatif; Madalina Condrescu
Journal:  J Physiol       Date:  2008-01-31       Impact factor: 5.182

6.  Adenovirus mediated-gene transfer into cardiomyocytes.

Authors:  L A Kirshenbaum
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

7.  Ras binding triggers ubiquitination of the Ras exchange factor Ras-GRF2.

Authors:  C L de Hoog; J A Koehler; M D Goldstein; P Taylor; D Figeys; M F Moran
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

8.  GATA4 expression is primarily regulated via a miR-26b-dependent post-transcriptional mechanism during cardiac hypertrophy.

Authors:  Mingyue Han; Zhi Yang; Danish Sayed; Minzhen He; Shumin Gao; Lin Lin; Seonghun Yoon; Maha Abdellatif
Journal:  Cardiovasc Res       Date:  2012-01-04       Impact factor: 10.787

9.  The Rho family G proteins play a critical role in muscle differentiation.

Authors:  H Takano; I Komuro; T Oka; I Shiojima; Y Hiroi; T Mizuno; Y Yazaki
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

10.  Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21.

Authors:  José M Escandell; Pawan Kaler; M Carmen Recio; Takehiko Sasazuki; Senji Shirasawa; Leonard Augenlicht; José-Luis Ríos; Lidija Klampfer
Journal:  Biochem Pharmacol       Date:  2008-05-08       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.